This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • How accurate is the supplement content in both generic and branded ophthalmology supplements?

How accurate is the supplement content in both generic and branded ophthalmology supplements?
Reviewed by Tasmin Berman

5 October 2020 | Tasmin Berman | EYE - Vitreo-Retinal
Share This

This prospective cross-section study compared the concentrations of Vitamin C, Vitamin E, Zinc, and Copper in five dietary supplements including both national and regional brands used for macular degeneration in the United States. They performed a comparative analysis using gas chromatography-mass spectrometry for Vitamin C, Vitamin E, Zinc and Copper content. Analysis using atomic absorption spectroscopy assessed whether the labelling of vitamin content was accurate. They found that the average percentage change for the vitamins compared to what was listed was 27.3% for Vitamin C, 3.7% for Vitamin E, 17.5% for Zinc and 17% for Copper. They compared the finding to the recommended daily dosage recommended in the AREDSII study and found four of the five products to have lower dosage than the recommendations. They found that both tablet and gel forms of supplements were relatively accurate compared to their product labelling. In some cases, the supplements contained higher than the manufacturers labelling but this was found to not be a level that would cause harm. The study suggests here there is no major difference between generic and branded products however they do not meet the recommended doses from the AREDSII study, and this should be considered when recommending such products especially in those patients with higher risk factors for age-related macular degeneration. – TB

Vitamin analysis comparison study.
Fleissig E, Apenbrinck E, Zhang X, et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY
August 2020 [Epub ahead of print].
Share This
CONTRIBUTOR
Tasmin Berman

University of Liverpool, Liverpool, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency